Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening.  More details

06/03/2022

Validation of a multimodal blood-based test for the detection of colorectal cancer with sub single molecule sensitivity

Blood-based colorectal cancer (CRC) screening tests can improve adherence to screening guidelines…

Back to Blog Listing

Sign up to receive the latest updates on ShieldTM

By clicking the button above, you agree to receive periodic product-related updates via email from Guardant Health.